comparemela.com
  1. Home
  2. Live Updates
  3. Adcentrx Therapeutics - Breaking News

Latest Breaking News On - Adcentrx therapeutics - Page 2 : comparemela.com

China Digest: Adcentrx raises $13m; Vision Plus Capital backs Fantuan

Founded in 2021, Adcentrx Therapeutics, which has a Shanghai office, aims to advance at least one candidate into the clinical stage each year.

United kingdomUnited statesSoult ukpyolsiSouth koreaEight roads ventures backed adcentrx therapeuticsVision plus capitalSan diego basedAntibody drug conjugateQuan capitalPartners investmentEight roads venturesAdcentrx therapeuticAdcentrx therapeuticsAplus capitalCeltic house asiaNorth america

Adcentrx Therapeutics Closes $38M Series A+ Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San diegoUnited statesHui liTrinity innovation fundAdcentrx therapeuticsAntibody drug conjugateEight roads venturesF prime capitalDelta capital

Adcentrx Therapeutics Announces Completion of $38 million Series A+ Financing Led by Eight Roads Ventures

/PRNewswire/ Adcentrx Therapeutics ("Adcentrx"), a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer.

Meng jiangArunachal pradeshInnovent biologicsJeff jonasTao huangHui liTrinity innovation fundConsumer servicesAntibody drug conjugateEight roads venturesF prime capitalDelta capitalVenture partnersLighthouse capitalEight roadsVenture capital

Eight Roads Ventures leads Adcentrx Therapeutics s $38m extended Series A round

Eight Roads Ventures leads Adcentrx Therapeutics s $38m extended Series A round
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Trinity innovation fundAdcentrx therapeuticsSan diego headquarteredAntibody drug conjugateEight roadsCambridge basedf prime capitalBeijing based trinity innovation fundDelta capitalBoyu capital

Biotech veteran Jeff Jonas on leaving Sage, guiding new biotechs and his personal odyssey

BioPharma

United statesBarry greeneJeff jonasAdcentrx therapeuticsEnsem therapeuticsPharma dive

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.